What we do
Centro Studi GISED has established Psonet, an international registry of systematic treatments for psoriasis in Europe, with the aim of obtaining safety and effectiveness data. A special focus is on the so-called "biologicals", i.e., drugs obtained by molecular biology techniques, such as etanercept, infliximab, adalimumab, ustekinumab and others. Uncertainties still exist about the long term safety and efficacy profile of these new drugs.
Back to research project